Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients

Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients

Opis bibliograficzny
Główni autorzy:	Lily, O, Palace, J, Vincent, A
Format:	Journal article
Wydane:	2002

Podobne zapisy

Serum autoantibodies against intracellular antigens in multiple sclerosis
od: Lily, O, i wsp.
Wydane: (2002)

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
od: Lily, O, i wsp.
Wydane: (2004)

Serum Anti-oligodendrocyte Autoantibodies in Patients With Multiple Sclerosis Detected by a Tissue-Based Immunofluorescence Assay
od: Yukino Miyachi, i wsp.
Wydane: (2021-08-01)

Pathogenic autoantibodies to neuronal proteins in neurological disorders.
od: Vincent, A, i wsp.
Wydane: (1999)

An approach to the identification of targets of autoantibodies in multiple sclerosis
od: Littleton, E, i wsp.
Wydane: (2004)

Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies.
od: Littleton, E, i wsp.
Wydane: (2009)

3285 Toxicity of Released B Cell Products in Multiple Sclerosis: Effects on Neurons and Oligodendrocytes
od: Leah Zuroff, i wsp.
Wydane: (2019-03-01)

Oligodendrocyte Injury in Multiple Sclerosis.
od: Mateo Përgjegji, i wsp.
Wydane: (2025-01-01)

Towards defining antigenic targets for antibodies in multiple sclerosis
od: Littleton, E, i wsp.
Wydane: (2006)

Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis.
od: Tüzün, E, i wsp.
Wydane: (2011)

Autoantigens and Autoantibodies in Multiple Sclerosis
od: Abbas Mirshafiey, i wsp.
Wydane: (2013-12-01)

Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis
od: Nadjet Gacem, i wsp.
Wydane: (2021-04-01)

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis
od: Jurynczyk, M, i wsp.
Wydane: (2017)

MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
od: Océane Perdaens, i wsp.
Wydane: (2024-02-01)

The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies
od: Adriana Octaviana Dulamea
Wydane: (2017-01-01)

Grey matter neuronal loss in multiple sclerosis
od: Cifelli, A, i wsp.
Wydane: (2002)

Age influenced cattle serum antigen detected by autoantibodies
od: Bettini TM, i wsp.
Wydane: (1974-10-01)

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
od: J. Q. Alida Chen, i wsp.
Wydane: (2025-01-01)

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.
od: Wegner, C, i wsp.
Wydane: (2006)

Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?
od: Morgan W. Psenicka, i wsp.
Wydane: (2021-06-01)

A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
od: John A. Olsen, i wsp.
Wydane: (2016-08-01)

Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells
od: Panagiotis Douvaras, i wsp.
Wydane: (2014-08-01)

Semaphorin4A Is Cytotoxic to Oligodendrocytes and Is Elevated in Microglia and Multiple Sclerosis
od: Dominique F. Leitner, i wsp.
Wydane: (2015-05-01)

Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models
od: Zhixin Lei, i wsp.
Wydane: (2024-01-01)

Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke
od: Beuy Joob, i wsp.
Wydane: (2020-12-01)

Autoantibodies and Sjogren's Syndrome in multiple sclerosis, a reappraisal.
od: Andrew J Solomon, i wsp.
Wydane: (2013-01-01)

Flow cytometry as a new method for the detection of surface antigens/surface-binding autoantibodies
od: Blaes, F, i wsp.
Wydane: (2000)

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety
od: Shenghua Zong, i wsp.
Wydane: (2020-11-01)

Anti-Neuronal Autoantibodies (Cell Surface and Onconeural) and Their Association With Natural Autoantibodies in Synthetic Cannabinoid-Induced Psychosis
od: Lídia Hau, i wsp.
Wydane: (2022-05-01)

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
od: Kuniko Kohyama, i wsp.
Wydane: (2023-02-01)

The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?
od: Taghipour, K, i wsp.
Wydane: (2012)

Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients
od: Deepali Mathur, i wsp.
Wydane: (2017-07-01)

Profile of autoantibodies in systemic sclerosis
od: M. N. Starovoitova, i wsp.
Wydane: (2016-10-01)

Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect
od: Nicolas Daviaud, i wsp.
Wydane: (2023-03-01)

Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis
od: Milton Guilherme Forestieri Fernandes, i wsp.
Wydane: (2023-07-01)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
od: Theorell, J, i wsp.
Wydane: (2021)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
od: Jakob Theorell, i wsp.
Wydane: (2021-11-01)

Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad
od: Kreesan Reddy, i wsp.
Wydane: (2022-11-01)

The evaluation of a novel "goat serum" therapy (Aimspro) in multiple sclerosis
od: Burke, G, i wsp.
Wydane: (2005)

Antigen-bound and free β-amyloid autoantibodies in serum of healthy adults.
od: Madalina Maftei, i wsp.
Wydane: (2012-01-01)